DrugPatentWatch Database Preview

Desipramine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for desipramine hydrochloride and what is the scope of desipramine hydrochloride patent protection?

Desipramine hydrochloride is the generic ingredient in three branded drugs marketed by Sanofi Aventis Us, Actavis Totowa, Amneal Pharms Co, Ani Pharms Inc, Heritage Pharms Inc, Ingenus Pharms Llc, Sandoz, Usl Pharma, and Us Pharm Holdings, and is included in twenty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for desipramine hydrochloride. Fifteen suppliers are listed for this compound.

Summary for desipramine hydrochloride

US Patents:	0
Tradenames:	3
Applicants:	9
NDAs:	22
Drug Master File Entries:	9
Suppliers / Packagers:	15
Bulk Api Vendors:	46
Clinical Trials:	59
Patent Applications:	1,748
Formulation / Manufacturing:	see details
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for desipramine hydrochloride
DailyMed Link:	desipramine hydrochloride at DailyMed

Pharmacology for desipramine hydrochloride

Drug Class

Tricyclic Antidepressant

Medical Subject Heading (MeSH) Categories for desipramine hydrochloride

Adrenergic Uptake Inhibitors

Antidepressive Agents, Tricyclic

Enzyme Inhibitors

Synonyms for desipramine hydrochloride

[3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl]methylamine hydrochloride

10-11-Dihydro-N-methyl-5H-dibenz(Z)[b,f]azepine-5-propanamine hydrochloride

10,11-Dihydro-5-(3-(methylamino)prop-yl)-5h-dibenz(b,f)azepine hydro-chloride

10,11-Dihydro-5-(3-(methylamino)propyl)-5H-dibenz(b,f)azepine hydrochloride

10,11-Dihydro-5-(3-(methylamino)propyl)-5H-dibenz(b,f)azepine monohydrochloride

10,11-Dihydro-N-methyl-5H-dibenz-[b,f]azepine hydrochloride

10,f]azepine hydrochloride

10,f]azepine monohydrochloride

1Y58DO4MY1

3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methyl-propan-1-amine hydrochloride

3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methylpropan-1-amine hydrochloride

3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methylpropan-1-amine;hydrochloride

5-(3-Methylaminopropyl)-5H-dibenz[b,f]azepine hydrochloride

50-47-5 (Parent)

58-28-6

5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N-methyl-, monohydrochloride

5H-Dibenz(b,f)azepine, 10,11-dihydro-5-(3-(methylamino)propyl)-, hydrochloride

5H-Dibenz(b,f)azepine, 10,11-dihydro-5-(3-(methylamino)propyl)-, monohydrochloride

5H-Dibenz[b, 10,11-dihydro-5-[3-(methylamino)propyl]-, hydrochloride

5H-Dibenz[b, 10,11-dihydro-5-[3-(methylamino)propyl]-, monohydrochloride

5H-Dibenz[b, 10,11-dihydro-N-methyl-, monohydrochloride

AC1L2324

AKOS015994722

AN-083

B7261

BG0162

CAS-58-28-6

CC-26348

CCG-38909

CHEBI:4449

CHEMBL1696

CPD000036827

CS-8201

CTK8F9062

D 3900

D00812

Demethylimipramine hydrochloride

Desimipramine hydrochloride

Desimipramine, hydrochloride

Desipramine Hcl

Desipramine hydrochloride (JAN/USP)

Desipramine hydrochloride [USAN:JAN]

Desipramine hydrochloride [USAN:USP:JAN]

Desipramine Hydrochloride 1.0 mg/ml in Methanol (as free base)

Desipramine hydrochloride solution, drug standard, 1.0 mg/mL in methanol

Desipramine hydrochloride, >=98% (TLC), powder

Desipramine hydrochloride, European Pharmacopoeia (EP) Reference Standard

Desipramine Hydrochloride, pharmaceutical secondary standard; traceable to USP, PhEur, BP

Desipramine hydrochloride, United States Pharmacopeia (USP) Reference Standard

Desipramine monohydrochloride

Desiprimine

Desmethylimipramine chloride

Desmethylimipramine hydrochloride

Desmethylimipramine monohydrochloride

Desmethylimipramine-hydrochloride

DMI hydrochloride

DSSTox_CID_26942

DSSTox_GSID_46942

DSSTox_RID_82024

DTXSID9046942

EINECS 200-373-1

Epitope ID:224551

EU-0100358

EX 4355

EX-4355

FT-0603109

G 35020

G-35020

GMI

HMS1569E07

HMS1920C22

HY-B1272

Imipraminedemethyl hydrochloride

iren

JB 8181

JB-8181

KS-1296

LP00358

LS-60422

LT00771924

MFCD00058108

MLS000028418

MLS000038088

MLS001056757

MLS002222246

MLS002548871

MolPort-000-917-727

N-(.gamma.-Methylaminopropyl)iminodibenzyl hydrochloride

N-(gamma-Methylaminopropyl)iminodibenzyl hydrochloride

NC00681

NCGC00015340-02

NCGC00015340-14

NCGC00093794-01

NCGC00093794-02

NCGC00093794-03

NCGC00093794-04

NCGC00093794-05

NCGC00261043-01

Norpolake

Norpramin

Norpramin (TN)

Nortimil

NSC 114901

NSC-114901

NSC-756719

NSC114901

NSC756719

Opera_ID_943

Pertofran

Pertofrane

Pertofrin

Pertrofan

Petylyl

Pharmakon1600-01500227

Prestwick_706

REGID_for_CID_65327

RMI 9,384A

RMI-9384A

SAM002264605

SC-57976

SCHEMBL41992

SMR000036827

SPECTRUM1500227

SR-01000003060

SR-01000003060-2

Tox21_110129

Tox21_110129_1

Tox21_500358

UNII-1Y58DO4MY1

VA10690

WLN: T C676 BN&T&J B3M1 &GH

XAEWZDYWZHIUCT-UHFFFAOYSA-N

US Patents and Regulatory Information for desipramine hydrochloride

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Heritage Pharms Inc	DESIPRAMINE HYDROCHLORIDE	desipramine hydrochloride	TABLET;ORAL	207433-003	May 5, 2016	AB	RX	No	No
Ani Pharms Inc	DESIPRAMINE HYDROCHLORIDE	desipramine hydrochloride	TABLET;ORAL	071803-004	Dec 8, 1987		DISCN	No	No
Actavis Totowa	DESIPRAMINE HYDROCHLORIDE	desipramine hydrochloride	TABLET;ORAL	071601-001	Jun 5, 1987	AB	RX	No	No
Heritage Pharms Inc	DESIPRAMINE HYDROCHLORIDE	desipramine hydrochloride	TABLET;ORAL	207433-005	May 5, 2016	AB	RX	No	No

Expired US Patents for desipramine hydrochloride

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Us Pharm Holdings	NORPRAMIN	desipramine hydrochloride	TABLET;ORAL	014399-001	Approved Prior to Jan 1, 1982
Sanofi Aventis Us	PERTOFRANE	desipramine hydrochloride	CAPSULE;ORAL	013621-001	Approved Prior to Jan 1, 1982
Sanofi Aventis Us	PERTOFRANE	desipramine hydrochloride	CAPSULE;ORAL	013621-002	Approved Prior to Jan 1, 1982
Us Pharm Holdings	NORPRAMIN	desipramine hydrochloride	TABLET;ORAL	014399-006	Approved Prior to Jan 1, 1982